Breast Cancer Now - the UK’s largest breast cancer charity dedicated to funding world-class research - was created by the merger of Breast Cancer Campaign and Breakthrough Breast Cancer. For more than 25 years as separate charities, we were committed to funding the very best in breast cancer research across prevention, diagnosis, treatments and secondary breast cancer. Our ambition was simple, and it was shared: to find a way to stop women dying from breast cancer.
Our Annual Report represents an amalgamation of results – the legacy charities results up to the 31 March 2015 plus the results of the combined charity, Breast Cancer Now, from 1 April to 31 July 2015. At a time of increased public scrutiny of charities, when supporters are rightly concerned about how their generous donations are being used, we are committed to acting in the best interest of our beneficiaries – people affected by breast cancer – and as such, embrace the opportunity to be transparent about how we work.
We hope you find our first Annual Report as Breast Cancer Now interesting and inspiring, and are happy to answer any questions you may have.
Breast Cancer Now annual report
Legacy charity accounts
Download the annual report and accounts for Breast Cancer Campaign and Breakthrough Breast Cancer, the two charities that merged in June 2015 to form Breast Cancer Now.
Breast Cancer Campaign annual reports
Breakthrough Breast Cancer annual reports
Pharmaceutical donations 2013 - 2015
The Breast Cancer Now Catalyst Programme
The Breast Cancer Now Catalyst Programme, is an initiative which aims to bring together Europe’s leading breast cancer researchers and the world’s leading pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050. The first collaborator signed up to the Catalyst Programme is the biopharmaceutical company Pfizer. Pfizer has committed $15m USD (around £10m) over three years, which opens an exciting opportunity for breast cancer research.
The programme aims to enable Europe’s leading researchers to design independently selected research programmes, using companies’ existing breast cancer drugs or molecules that they’re still working on in their laboratories. We aim to speed up the translation of research into new more effective targeted treatments and therapies for breast cancer patients. Find out more about the Breast Cancer Now Catalyst Programme.
Please contact our Supporter Engagement team with any questions by emailing firstname.lastname@example.org or calling 0333 20 70 300.